Advitech Announces a Mandate to Group Crea and Administrative Changes.QUEBEC -- Advitech(TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension VENTURE:AVI (Audio Video Interleaved) A Windows multimedia video format from Microsoft. It interleaves standard waveform audio and digital video frames (bitmaps) to provide reduced animation at 15 fps at 160x120x8 resolution. Audio is 11,025Hz, 8-bit samples. ).To assist the society in its financing program and to further evaluate new marketing opportunities for its products portfolio, Advitech has mandated Group Crea and more specifically Mr Rene Gosselin MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration , partner of Group Crea. Mr Gosselin has been involved for many years with biotech companies and has a strong background with the financing and the management of such companies. He sits on the board of directors in the sector of health science and biotechnology. The mandate of Mr Gosselin started on January 4th for a non-specified duration. To help the society in technical and scientific servicing to marketing partners such as Cothera SAS (1) (SAS Institute Inc., Cary, NC, www.sas.com) A software company that specializes in data warehousing and decision support software based on the SAS System. Founded in 1976, SAS is one of the world's largest privately held software companies. See SAS System. and PhotoMedex (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :PHMD) and to launch Dermylex(TM), the society has renewed the mandate of Mr Jean Rousseau Ph.D. Mr Rousseau has been directly involved in the negotiation process with PhotoMedex and has brought a significant contribution to the development process of technical and scientific documentation requested for the marketing of Dermylex(TM). Finally, Mr Denis Denis, king of Portugal: see Diniz. Villeneuve has resigned as director of the corporation. Mr Claude Livernoche, Chairman of the board of the Corporation, thanks Mr Villeneuve for its contribution as a member of the board of directors of the Corporation. About Crea The Crea Group is a multidisciplinary consulting firm offering a complete array of integrated consulting services to assist companies, investors, universities and research centers in the achievement of technologically innovative projects within the industries of life sciences, biotechnology, agro-food and environment. With more than 10 highly qualified scientific and business professionals, the Crea Group team will accomplish feasibility studies, develop business plans, implement strategies as well as propose ways to finance investment projects or company growth. Its professionals are able to craft optimal strategies and transactions targeted towards health sciences and biotechnology industries in order to achieve one's business goals and objectives, maximizing investment returns for the company and its shareholders. About Advitech Advitech is a biotechnology company specializing in the development of clinically tested bioactive bi·o·ac·tive adj. Of or relating to a substance that has an effect on living tissue. bioactive having an effect on or eliciting a response from living tissue. ingredients for chronic immune-mediated inflammatory diseases (I.M.I.D.), such as psoriasis and inflammatory bowel diseases inflammatory bowel disease n. Abbr. IBD Any of several incurable and debilitating diseases of the gastrointestinal tract characterized by inflammation and obstruction of parts of the intestine. . Advitech has recently announces marketing agreements for DermylexTM with Cothera SAS and PhotoMedex (NASDAQ:PHMD). Advitech's common shares are listed on the TSX Venture Exchange TSX Venture Exchange Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors. under the symbol AVI. The number of common shares outstanding is 54,799,818. About Dermylex(TM) Dermylex(TM) is Advitech's orally administered product for mild to moderate plaque psoriasis. Dermylex(TM) is based on Advitech's XP-828L, a bioactive ingredient with proven clinical efficacy. On July 5, 2005, the Company reported positive results from its Phase II clinical trial Noun 1. phase II clinical trial - a clinical trial on more persons than in phase I; intended to evaluate the efficacy of a treatment for the condition it is intended to treat; possible side effects are monitored phase II of XP-828L for treating mild to moderate psoriasis. The 112-day, multi-center, double blind, placebo-controlled study, involving 84 patients, confirmed the efficacy and excellent safety profile of XP-828L for treating mild to moderate psoriasis. This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The TSX Venture Exchange does not accept responsibility for the ad equacy or accuracy of this release. Advitech Inc. (TSX VENTURE:AVI) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion